Compass Therapeutics' Debt Round

Compass Therapeutics raised a round of funding on June 14, 2014.

Compass Therapeutics, formerly Kairos Biologics Foundation, is comprehensively drugging the tumor-immune synapse with human antibodies against over 50 cell surface and soluble targets.…

Articles about Compass Therapeutics' Debt Round: